Iron, metabolic syndrome, nonalcoholic fatty liver disease and carotid atherosclerosis

Atherosclerosis

Volumn 205, Issue 1, 2009, Pages 39-40

  Mascitelli, Luca ^a   Pezzetta, Francesca ^b   Goldstein, Mark R ^c  

^a Medical Service   (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

^c Fountain Medical Court ^*  (United States)

Author keywords

Atherosclerosis; Iron; Liver; Metabolic syndrome

Indexed keywords

CD71 ANTIGEN; FERRITIN; INSULIN; IRON;

ATHEROGENESIS; ATHEROMA; ATHEROSCLEROSIS; CAROTID ARTERY DISEASE; CELL INFILTRATION; DISEASE ASSOCIATION; DISEASE COURSE; FERRITIN BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; IRON METABOLISM; IRON STORAGE; LETTER; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER NECROSIS; MACROPHAGE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; STELLATE CELL;

CAROTID ARTERY DISEASES; FATTY LIVER; FERRITINS; HUMANS; INSULIN RESISTANCE; IRON; METABOLIC SYNDROME X; RECEPTORS, TRANSFERRIN;

EID: 67449107235     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2008.12.021     Document Type: Letter

References (12)

1. Kim HC, Kim DJ, Huh KB. Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis. 2008 September 19. [Epub ahead of print], doi:10.1016/j.atherosclerosis.2008.09.012.
2. Trombini P., and Piperno A. Ferritin, metabolic syndrome and NAFLD: elective attractions and dangerous liaisons. J Hepatol 46 (2007) 549-552
3. Bozzini C., Girelli D., Olivieri O., et al. Prevalence of body iron excess in the metabolic syndrome. Diabetes Care 28 (2005) 2061-2063
4. Fernandez-Real J.M., Ricart-Engel W., Arroyo E., et al. Serum ferritin as a component of the insulin resistance syndrome. Diabetes Care 21 (1998) 62-68
5. Zelber-Sagi S., Nitzan-Kaluski D., Halpern Z., and Oren R. NAFLD and hyperinsulinemia are major determinants of serum ferritin levels. J Hepatol 46 (2007) 700-707
6. George D.K., Goldwurm S., MacDonald G.A., et al. Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114 (1998) 311-318
7. Valenti L., Fracanzani A.L., Dongiovanni P., et al. Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study. Am J Gastroenterol 102 (2007) 1251-1258
8. Aigner E., Theurl I., Theurl M., et al. Pathways underlying iron accumulation in human nonalcoholic fatty liver disease. Am J Clin Nutr 87 (2008) 1374-1383
9. Li W., Xu L.H., Forssell C., Sullivan J.L., and Yuan X.M. Overexpression of transferrin receptor and ferritin related to clinical symptoms and destabilization of human carotid plaques. Exp Biol Med 233 (2008) 818-826
10. Kiechl S., Willeit J., Egger G., Poewe W., and Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 96 (1997) 3300-3307
11. Wolff B., Völzke H., Lüdemann J., et al. Association between high serum ferritin levels and carotid atherosclerosis in the study of health in Pomerania (SHIP). Stroke 35 (2004) 453-457
12. Engberink M.F., Geleijnse J.M., Durga J., et al. Blood donation, body iron status and carotid intima-media thickness. Atherosclerosis 196 (2008) 856-862